![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 2223 |
FusionGeneSummary for APOE_SNW1 |
![]() |
Fusion gene information | Fusion gene name: APOE_SNW1 | Fusion gene ID: 2223 | Hgene | Tgene | Gene symbol | APOE | SNW1 | Gene ID | 348 | 22938 |
Gene name | apolipoprotein E | SNW domain containing 1 | |
Synonyms | AD2|APO-E|ApoE4|LDLCQ5|LPG | Bx42|FUN20|NCOA-62|PRPF45|Prp45|SKIIP|SKIP|SKIP1 | |
Cytomap | 19q13.32 | 14q24.3 | |
Type of gene | protein-coding | protein-coding | |
Description | apolipoprotein Eapolipoprotein E3 | SNW domain-containing protein 1SKI interacting proteinhomolog of Drosophila BX42nuclear protein SkiPnuclear receptor coactivator NCoA-62nuclear receptor coactivator, 62-kDski-interacting protein | |
Modification date | 20180527 | 20180519 | |
UniProtAcc | P02649 | Q13573 | |
Ensembl transtripts involved in fusion gene | ENST00000252486, | ENST00000261531, ENST00000554775, ENST00000555761, | |
Fusion gene scores | * DoF score | 9 X 4 X 4=144 | 15 X 4 X 12=720 |
# samples | 10 | 16 | |
** MAII score | log2(10/144*10)=-0.526068811667588 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(16/720*10)=-2.16992500144231 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: APOE [Title/Abstract] AND SNW1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | APOE | GO:0001937 | negative regulation of endothelial cell proliferation | 9685360 |
Hgene | APOE | GO:0006641 | triglyceride metabolic process | 9649566 |
Hgene | APOE | GO:0006898 | receptor-mediated endocytosis | 1917954 |
Hgene | APOE | GO:0007186 | G-protein coupled receptor signaling pathway | 16443932 |
Hgene | APOE | GO:0007263 | nitric oxide mediated signal transduction | 8995232 |
Hgene | APOE | GO:0008203 | cholesterol metabolic process | 9649566 |
Hgene | APOE | GO:0010544 | negative regulation of platelet activation | 8995232 |
Hgene | APOE | GO:0010873 | positive regulation of cholesterol esterification | 15654758 |
Hgene | APOE | GO:0010875 | positive regulation of cholesterol efflux | 12042316|14754908 |
Hgene | APOE | GO:0010976 | positive regulation of neuron projection development | 7592957|23845000 |
Hgene | APOE | GO:0010977 | negative regulation of neuron projection development | 7592957 |
Hgene | APOE | GO:0015909 | long-chain fatty acid transport | 24345162 |
Hgene | APOE | GO:0017038 | protein import | 24446231 |
Hgene | APOE | GO:0019934 | cGMP-mediated signaling | 8995232 |
Hgene | APOE | GO:0030195 | negative regulation of blood coagulation | 8995232 |
Hgene | APOE | GO:0030828 | positive regulation of cGMP biosynthetic process | 8995232 |
Hgene | APOE | GO:0032462 | regulation of protein homooligomerization | 25207746 |
Hgene | APOE | GO:0032489 | regulation of Cdc42 protein signal transduction | 16443932 |
Hgene | APOE | GO:0032805 | positive regulation of low-density lipoprotein particle receptor catabolic process | 15950758 |
Hgene | APOE | GO:0033344 | cholesterol efflux | 11162594|16443932 |
Hgene | APOE | GO:0033700 | phospholipid efflux | 11162594 |
Hgene | APOE | GO:0034372 | very-low-density lipoprotein particle remodeling | 15654758 |
Hgene | APOE | GO:0034380 | high-density lipoprotein particle assembly | 17305370 |
Hgene | APOE | GO:0034384 | high-density lipoprotein particle clearance | 210175 |
Hgene | APOE | GO:0034447 | very-low-density lipoprotein particle clearance | 1917954 |
Hgene | APOE | GO:0042632 | cholesterol homeostasis | 9649566 |
Hgene | APOE | GO:0042982 | amyloid precursor protein metabolic process | 21593558 |
Hgene | APOE | GO:0043407 | negative regulation of MAP kinase activity | 9685360 |
Hgene | APOE | GO:0043537 | negative regulation of blood vessel endothelial cell migration | 9685360 |
Hgene | APOE | GO:0043691 | reverse cholesterol transport | 8127890 |
Hgene | APOE | GO:0045541 | negative regulation of cholesterol biosynthetic process | 1917954 |
Hgene | APOE | GO:0045807 | positive regulation of endocytosis | 7683668|8300609 |
Hgene | APOE | GO:0046889 | positive regulation of lipid biosynthetic process | 12042316 |
Hgene | APOE | GO:0051000 | positive regulation of nitric-oxide synthase activity | 8995232 |
Hgene | APOE | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis | 15950758 |
Hgene | APOE | GO:0055089 | fatty acid homeostasis | 24345162 |
Hgene | APOE | GO:0060999 | positive regulation of dendritic spine development | 24328732 |
Hgene | APOE | GO:0090090 | negative regulation of canonical Wnt signaling pathway | 16805831 |
Hgene | APOE | GO:0097113 | AMPA glutamate receptor clustering | 24328732 |
Hgene | APOE | GO:0097114 | NMDA glutamate receptor clustering | 24328732 |
Hgene | APOE | GO:1900221 | regulation of amyloid-beta clearance | 24446231 |
Hgene | APOE | GO:1900272 | negative regulation of long-term synaptic potentiation | 16273551 |
Hgene | APOE | GO:1901215 | negative regulation of neuron death | 24259049 |
Hgene | APOE | GO:1901628 | positive regulation of postsynaptic membrane organization | 24259049 |
Hgene | APOE | GO:1901630 | negative regulation of presynaptic membrane organization | 24259049 |
Hgene | APOE | GO:1902430 | negative regulation of amyloid-beta formation | 24154541 |
Hgene | APOE | GO:1902952 | positive regulation of dendritic spine maintenance | 24328732 |
Hgene | APOE | GO:1902995 | positive regulation of phospholipid efflux | 12042316 |
Hgene | APOE | GO:1903002 | positive regulation of lipid transport across blood brain barrier | 24345162 |
Hgene | APOE | GO:1905855 | positive regulation of heparan sulfate binding | 7683668 |
Hgene | APOE | GO:1905860 | positive regulation of heparan sulfate proteoglycan binding | 8300609 |
Hgene | APOE | GO:1905890 | regulation of cellular response to very-low-density lipoprotein particle stimulus | 7592957 |
Hgene | APOE | GO:1905906 | regulation of amyloid fibril formation | 25207746 |
Tgene | SNW1 | GO:0000122 | negative regulation of transcription by RNA polymerase II | 14985122 |
Tgene | SNW1 | GO:0000398 | mRNA splicing, via spliceosome | 15194481|28076346 |
Tgene | SNW1 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway | 11278756 |
Tgene | SNW1 | GO:0043923 | positive regulation by host of viral transcription | 15905409 |
Tgene | SNW1 | GO:0045892 | negative regulation of transcription, DNA-templated | 10713164|15878163 |
Tgene | SNW1 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 14985122|19934264 |
Tgene | SNW1 | GO:0048384 | retinoic acid receptor signaling pathway | 19934264 |
Tgene | SNW1 | GO:0048385 | regulation of retinoic acid receptor signaling pathway | 14985122 |
Tgene | SNW1 | GO:0070562 | regulation of vitamin D receptor signaling pathway | 14985122 |
Tgene | SNW1 | GO:0070564 | positive regulation of vitamin D receptor signaling pathway | 9632709|11514567 |
Tgene | SNW1 | GO:0071300 | cellular response to retinoic acid | 19934264 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | LIHC | TCGA-BC-A8YO-01A | APOE | chr19 | 45412650 | + | SNW1 | chr14 | 78189203 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000252486 | ENST00000261531 | APOE | chr19 | 45412650 | + | SNW1 | chr14 | 78189203 | - |
5CDS-intron | ENST00000252486 | ENST00000554775 | APOE | chr19 | 45412650 | + | SNW1 | chr14 | 78189203 | - |
5CDS-intron | ENST00000252486 | ENST00000555761 | APOE | chr19 | 45412650 | + | SNW1 | chr14 | 78189203 | - |
Top |
FusionProtFeatures for APOE_SNW1 |
![]() |
Hgene | Tgene |
APOE | SNW1 |
Mediates the binding, internalization, and catabolism oflipoprotein particles. It can serve as a ligand for the LDL (apoB/E) receptor and for the specific apo-E receptor (chylomicronremnant) of hepatic tissues. {ECO:0000303|PubMed:3283935}. | Involved in pre-mRNA splicing as component of thespliceosome (PubMed:11991638, PubMed:28502770, PubMed:28076346).Is required in the specific splicing of CDKN1A pre-mRNA; thefunction probably involves the recruitment of U2AF2 to the mRNA.Is proposed to recruit PPIL1 to the spliceosome. May be involvedin cyclin-D1/CCND1 mRNA stability through the SNARP complex whichassociates with both the 3'end of the CCND1 gene and its mRNA.Involved in transcriptional regulation. Modulates TGF-beta-mediated transcription via association with SMAD proteins, MYOD1-mediated transcription via association with PABPN1, RB1-mediatedtranscriptional repression, and retinoid-X receptor (RXR)- andvitamin D receptor (VDR)-dependent gene transcription in a cellline-specific manner probably involving coactivators NCOA1 andGRIP1. Is involved in NOTCH1-mediated transcriptional activation.Binds to multimerized forms of Notch intracellular domain (NICD)and is proposed to recruit transcriptional coactivators such asMAML1 to form an intermediate preactivation complex whichassociates with DNA-bound CBF-1/RBPJ to form a transcriptionalactivation complex by releasing SNW1 and redundant NOTCH1 NICD.{ECO:0000269|PubMed:10644367, ECO:0000269|PubMed:11278756,ECO:0000269|PubMed:11371506, ECO:0000269|PubMed:11514567,ECO:0000269|PubMed:11991638, ECO:0000269|PubMed:12840015,ECO:0000269|PubMed:14985122, ECO:0000269|PubMed:15194481,ECO:0000269|PubMed:15905409, ECO:0000269|PubMed:18794151,ECO:0000269|PubMed:19818711, ECO:0000269|PubMed:21245387,ECO:0000269|PubMed:21460037, ECO:0000269|PubMed:28076346,ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:9632709}. (Microbial infection) Is recruited by HIV-1 Tat toTat:P-TEFb:TAR RNA complexes and is involved in Tat transcriptionby recruitment of MYC, MEN1 and TRRAP to the HIV promoter.{ECO:0000269|PubMed:15905409, ECO:0000269|PubMed:19818711}. (Microbial infection) Proposed to be involved intranscriptional activation by EBV EBNA2 of CBF-1/RBPJ-repressedpromoters. {ECO:0000269|PubMed:10644367}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for APOE_SNW1 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for APOE_SNW1 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
APOE | LRP8, PLTP, LRP2, A2M, MAPT, NEFM, LRP1, CSNK2A1, GCDH, PDCD4, CDC37, CYP2C8, ECSIT, IFIT3, LOXL4, MAST1, PSEN1, RNF32, APOE, C19orf52, CYP2C18, ELAVL1, FARSA, FBXL12, IFIT5, LONP1, NOS3, PRAM1, PRDX2, RHEB, ST13, ACTG1, ANKH, EPN2, FOXG1, FXYD7, HTRA1, IQSEC1, MID1IP1, PCMT1, PLEKHA6, RPL4, TYRO3, ZNF558, ALB, LCAT, ARFGAP1, HLA-DPA1, VDAC1, MMRN1, MMP3, MANSC1, C9, VDAC3, MMP10, IFNA8 | SNW1 | SKI, RBPJ, CIR1, HDAC2, SIN3A, NCOR2, SND1, NOTCH1, NOTCH3, ASCC2, RB1, RBL1, RBL2, SMAD2, SMAD3, SMAD4, SKIL, VDR, PABPN1, MYOD1, RXRA, NCOA2, NCOA1, TCEA2, CCNT1, MYC, CDK9, KMT2A, MEN1, IKBKG, PCBD2, TRIM15, ZSCAN1, SRRM1, NCOR1, EP300, TADA2A, PRPF8, UBR5, ZMAT3, EFTUD2, HNRNPU, DDB1, SFPQ, DDX23, CDC5L, HSPA5, PFKL, ABCF2, TUBB4A, EEF1G, EEF1A1, TUBB1, MSH2, NR0B1, NR0B2, ACTN2, CKAP5, MAPK6, TNNT1, VAV2, SIRT7, PRKAA2, CUL3, CUL2, DAXX, LNX1, MAGEA1, TOP1, PABPC1, CWC27, DHX38, SKIV2L2, DHX15, SNRPD2, DDX5, RAD21, EIF4A3, MAGOH, NHP2L1, SART1, CTNNBL1, XAB2, SNIP1, MFAP1, ZNF830, CXorf56, TTC14, HDAC11, HECW2, AURKB, TP53, TUBGCP3, GOLGA2, TRAF1, IKZF1, MTUS2, TFIP11, PPIL1, CEP55, TEX11, RINT1, LZTS2, KRT40, NXF1, MSL1, ZDHHC17, CUL7, OBSL1, SIRT1, RARA, SUZ12, RNF2, BMI1, OCLN, SNRPA1, DHX8, TSSC4, USB1, FHL3, PPIE, WDR83, CCDC94, LUC7L2, HSPB1, NTRK1, GCN1L1, HARS, HNRNPR, PFKM, PRPF4, SEPT2, SEPT7, SNRNP200, BUD31, CDC40, CRNKL1, PFKP, PLRG1, PRPF19, SARS, TRMT6, SYF2, TTC37, VARS, MUS81, KRAS, SF3B4, SYNCRIP, CPSF4, HNRNPA0, EBNA1BP2, CLP1, CPSF6, SRSF3, HNRNPA3, RBMX, CPSF1, HNRNPA1, HNRNPAB, HNRNPD, NCBP1, PCF11, LUC7L3, PPP2R1B, PRPF40A, METTL3, SRSF2, SRSF5, SRSF6, SNRPB2, RBM10, SRSF11, DDX46, PPP1CA, LOC102724594, BCAS2, SF3A1, CHERP, SF3A3, SF3B2, DDX42, U2AF2, HNRNPK, TRUB1, CSTF3, ELAVL1, XRN2, SNW1, U2SURP, TARDBP, SF3B3, SF3B1, PRPF6, FUS, HNRNPA2B1, HNRNPC, HNRNPF, HNRNPH1, HSPA8, HNRNPM, NONO, GEMIN4, PCBP1, SF3B6, CPSF3, EXOSC10, CPSF2, LUC7L, RBM4, SRSF1, SMN1, SMN2, SNRNP70, SNRPD3, U2AF1, CPSF7, RBM17, HNRNPLL, SNRNP40, RBM39, BZW1, PDCD6IP, SNUPN, ACTR1A, CDK3, STAG1, TUBB3, SEC23B, ARFGEF2, MAGED2, COPS6, CHD3, CHD4, WDR5, PKP3, KTI12, ARAP1, CSK, DCTN1, DDX1, DHX9, DOCK1, DOCK2, MLKL, CTTN, PUF60, ACIN1, WAPAL, XPO6, DNAJC13, SRRM2, GTPBP4, XRCC6, NIPBL, SEC31B, LDLRAP1, KIAA1279, ZNF326, BABAM1, GSPT1, OLA1, PIK3R4, IK, ILK, KPNA1, MLH1, ATM, PAK1, METTL13, CDK12, POLE, ATR, APBB1IP, ATRX, PPP2R1A, KIF27, UBE2Q1, CHD7, PRKAG1, ASUN, EXOC1, CAND1, MAP2K2, MAP2K3, LRRC47, TAOK1, PURA, WIZ, BLM, NCAPG, RBM15, YTHDC2, SRP19, AURKA, TTK, VASP, VRK1, NUP37, SPATA5L1, SHOC2, FIP1L1, DIAPH3, RIOK1, USP48, FYTTD1, RAE1, COPS3, API5, AP3B1, FUBP1, CPNE3, OTULIN, BCL7C, TRIP12, GNA14, AQR, CDK1, TOX4, G3BP2, NUP153, PSMC3, ACTB, SMC4, DNM1L, TUBB, ACTR2, RAD50, TRAP1, TUBA4A, PSMC6, DDX39A, PAK4, TUBB4B, NDC80, DCTN2, CCT7, CCT4, CCT2, EXOC5, KHDRBS1, CCT8, NUDC, SEPT9, TUBGCP2, RUVBL2, SUGT1, EHD1, KIF2C, CHEK1, DDX19B, PSMC1, RBM45, COPA, COPB1, CSE1L, AP1B1, SPATA5, DFNA5, DIAPH1, DYNC1LI2, DNM2, DSP, FASN, LRWD1, FEN1, COPG1, RALY, CCT5, CNOT1, MDN1, EXOC7, SMCHD1, NCAPH, ORC6, ORC3, KIF4A, HSPA12A, INTS1, PHGDH, VPS33B, COPG2, ZNF638, FHOD1, RACGAP1, MSH6, PARVB, HDLBP, HELLS, EHD4, DNAJA1, HSP90AA1, HSP90AB1, HSPD1, ARCN1, KIF11, KPNB1, KPNA2, LIMS1, LMNA, MRE11A, MYH9, NBN, DRG1, NSF, ORC2, ORC4, ORC5, UCHL5, DDX41, GULP1, RTCB, PLEC, PLK1, PNN, POLD1, ANLN, RIF1, FANCI, DDX19A, ABCF3, WDR33, CDKN2AIP, KIF21A, FERMT1, LRRC40, SCYL2, NSUN5, IPO9, ENAH, PARVA, EXOC2, PKN2, UNC45A, PRKDC, MAP2K7, RAD18, SMARCAD1, PSMC2, PSMC4, PSMC5, PSMD1, PSMD2, PSMD3, PSMD11, PSMD12, PSMD13, WDR18, TWF1, SHROOM3, CHD8, RANBP2, RANGAP1, RBBP5, RBBP7, UPF1, RFC2, RFC3, RFC4, RFC5, EXOC4, RPA1, SRSF7, ANAPC1, EPS8L2, FAM129B, INTS3, HLTF, SPTAN1, SPTBN1, SRP54, SRP68, SRP72, TCP1, BUB1, BUB1B, TLN1, TMPO, HSP90B1, CCT3, TUBG1, UBE2N, VIM, AHNAK, DDX39B, CDC73, UBA5, MYO15B, SYMPK, SEH1L, CAPG, SMC1A, UBL4A, ARID1A, CAPZA1, PICALM, EPPK1, NUF2, MAD1L1, CUL1, SMARCA5, RUVBL1, CDC23, IQGAP1, CCNB1, HIP1R, UBE2M, BTAF1, CCT6A, SMC3, ARHGEF1, DEPDC7, ARHGEF2, BUB3, PDLIM7, TRIP13, ROCK2, CHD1L, NUP155, NCAPD2, OXSR1, CDC27, MVP, TUBA1B, EXOC3, SNRPE, DVL3, ELAVL2, C11orf57, SNRPG, KIAA1143, SNRPF, ZC3H18, CD2BP2, EAPP |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for APOE_SNW1 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | APOE | P02649 | DB00062 | Human Serum Albumin | Apolipoprotein E | biotech | approved |
Hgene | APOE | P02649 | DB01593 | Zinc | Apolipoprotein E | small molecule | approved|investigational |
Top |
RelatedDiseases for APOE_SNW1 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | APOE | C0004153 | Atherosclerosis | 25 | CTD_human;HPO |
Hgene | APOE | C0011206 | Delirium | 5 | PSYGENET |
Hgene | APOE | C2936350 | Plaque, Atherosclerotic | 5 | CTD_human |
Hgene | APOE | C0001973 | Alcoholic Intoxication, Chronic | 4 | PSYGENET |
Hgene | APOE | C0002395 | Alzheimer's Disease | 4 | CTD_human;HPO |
Hgene | APOE | C0020443 | Hypercholesterolemia | 4 | CTD_human;HPO |
Hgene | APOE | C0020473 | Hyperlipidemia | 4 | CTD_human |
Hgene | APOE | C0020479 | Hyperlipoproteinemia Type III | 3 | CTD_human;ORPHANET |
Hgene | APOE | C2673196 | LIPOPROTEIN GLOMERULOPATHY | 3 | CTD_human;ORPHANET;UNIPROT |
Hgene | APOE | C0003850 | Arteriosclerosis | 2 | CTD_human |
Hgene | APOE | C0005586 | Bipolar Disorder | 2 | PSYGENET |
Hgene | APOE | C0020538 | Hypertensive disease | 2 | CTD_human |
Hgene | APOE | C0024121 | Lung Neoplasms | 2 | CTD_human |
Hgene | APOE | C0000786 | Spontaneous abortion | 1 | CTD_human |
Hgene | APOE | C0001418 | Adenocarcinoma | 1 | CTD_human |
Hgene | APOE | C0002726 | Amyloidosis | 1 | CTD_human |
Hgene | APOE | C0007222 | Cardiovascular Diseases | 1 | CTD_human |
Hgene | APOE | C0007273 | Carotid Artery Diseases | 1 | CTD_human |
Hgene | APOE | C0007282 | Carotid Stenosis | 1 | CTD_human |
Hgene | APOE | C0009241 | Cognition Disorders | 1 | CTD_human |
Hgene | APOE | C0010068 | Coronary heart disease | 1 | CTD_human |
Hgene | APOE | C0013990 | Pathological accumulation of air in tissues | 1 | CTD_human |
Hgene | APOE | C0019202 | Hepatolenticular Degeneration | 1 | CTD_human |
Hgene | APOE | C0020445 | Hypercholesterolemia, Familial | 1 | CTD_human;HPO |
Hgene | APOE | C0025427 | Mercury Poisoning | 1 | CTD_human |
Hgene | APOE | C0026769 | Multiple Sclerosis | 1 | CTD_human |
Hgene | APOE | C0027051 | Myocardial Infarction | 1 | CTD_human |
Hgene | APOE | C0027746 | Nerve Degeneration | 1 | CTD_human |
Hgene | APOE | C0028754 | Obesity | 1 | CTD_human;HPO |
Hgene | APOE | C0033687 | Proteinuria | 1 | CTD_human;HPO |
Hgene | APOE | C0033860 | Psoriasis | 1 | CTD_human |
Hgene | APOE | C0036341 | Schizophrenia | 1 | CTD_human |
Hgene | APOE | C0036489 | Sea-Blue Histiocyte Syndrome | 1 | CTD_human;HPO;ORPHANET |
Hgene | APOE | C0036572 | Seizures | 1 | CTD_human |
Hgene | APOE | C0038002 | Splenomegaly | 1 | CTD_human;HPO |
Hgene | APOE | C0085220 | Cerebral Amyloid Angiopathy | 1 | CTD_human;HPO |
Hgene | APOE | C0085762 | Alcohol abuse | 1 | PSYGENET |
Hgene | APOE | C0242339 | Dyslipidemias | 1 | CTD_human |
Hgene | APOE | C0242383 | Age related macular degeneration | 1 | CTD_human |
Hgene | APOE | C0751967 | Multiple Sclerosis, Relapsing-Remitting | 1 | CTD_human |
Hgene | APOE | C1384666 | hearing impairment | 1 | CTD_human |
Hgene | APOE | C1565489 | Renal Insufficiency | 1 | CTD_human;HPO |
Hgene | APOE | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |